FULL PROGRAMME
Thursday, November 24, 2016
14.00 – 15.00 Registration
15.00 – 15.15 Congress opening and welcome. Damjan Kovač (Ljubljana, Slovenia), Radoslav
Kveder (Ljubljana, Slovenia)
15.15 – 17.00 Oral presenations 1
Chairs: Bojan Novak (Izola, Slovenia), Sebastjan Bevc (Maribor, Slovenia)
17.00 – 17.30 Coffee break
17.30 – 18.30 Oral presentations 2
Chairs: Boštjan Leskovar (Trbovlje, Slovenia), Andrej Drozg (Celje, Slovenia)
18.30 – 19.00 Plenary lecture: Glucocorticoids in glomerular diseases – can we do without
them? Radoslav Kveder (Ljubljana, Slovenia)
20.00 Gala opening
Friday, November 25, 2016
8.00 – 10.00 Hemodialysis and acute kidney injury 1
Chairs: Vladimir Premru (Ljubljana, Slovenia), Vanja Peršič (Ljubljana, Slovenia)






8.00 – 8.10 Acute kidney injury: old problems, possible new strategies. Željka
Večerić Haler (Ljubljana, Slovenia)
8.20 – 8.35 Hemodialysis and apheresis in intensive care unit. Rafael Ponikvar
(Ljubljana, Slovenia)
8.40 – 8.55 Can we reduce the need for dialysis treatment of AKI (our
experience)? Marija Mravljak, Darja Kasnik, Martin Tretjak, Bojan Vujkovac
(Slovenj Gradec, Slovenia)
9.00 – 9.15 Citrate high cut-off hemodiafiltration in patients with cast chain
nephropathy. Andreja Marn Pernat (Ljubljana, Slovenia)
9.20 – 9.35 Hemodialysis in patients with communicable diseases. Ana Župunski
Čede (Ljubljana, Slovenia)
9.40 – 10.00 Discussion
10.00 – 10.30 Coffee break
10.30 – 13.00 Hemodialysis and acute kidney injury 2
Chairs: Robert Ekart (Maribor, Slovenia), Igor Rus (Jesenice, Slovenia)







10.30 – 10.55 Current state and future of hemodiafiltration. Francesco Locatelli
(Lecco, Italy)
11.00 – 11.15 Expanding use of citrate in acute and chronic hemodialysis.
Jadranka Buturović Ponikvar (Ljubljana, Slovenia)
11.20 – 11.35 Surveillance of vascular access by ultrasound: any sense? Marko
Malovrh (Ljubljana, Slovenia)
11.40 – 11.55 Approach to the elderly patient with advanced CKD. Jakob
Gubenšek (Ljubljana, Slovenia)
12.00 – 12.15 Motor abilities in hemodialysis patients – Slovenian findings. Jernej
Pajek (Ljubljana, Slovenia)
12.20 – 12.35 New views on the ethiopathogenesis and treatment of bone
disease in chronic dialysis patients. Miha Benedik (Ljubljana, Slovenia)
12.40 – 13.00 Discussion
13.00 – 14.00 Lunch
14.00 – 15.30 Industry Sponsored Symposium – Shire – Fabry School: Nephrology in Focus
Chair: Bojan Vujkovac (Slovenj Gradec, Slovenia)





14.00 – 14.05 Welcome and Objectives of Fabry School Nephrology. Bojan
Vujkovac (Slovenj Gradec, Slovenia)
14.05 – 14.25 Fabry Disease Overview. Martin Tretjak (Slovenj Gradec, Slovenia)
14.25 – 14.45 Organization of Fabry Disease Management in Slovenia. Andreja
Cokan Vujkovac (Slovenj Gradec, Slovenia)
14.45 – 15.05 Nephrology Aspects of Fabry Disease and Importance of Screening
in Proteinuric Patients. Bojan Vujkovac (Slovenj Gradec, Slovenia)
15.05 – 15.30 Interactive Panel Discusssion: How Can Nephrologists Contribute to
Earlier Diagnosis of Fabry Patients. Andreja Cokan Vujkovac, Bojan Vujkovac,
Martin Tretjak (Slovenj Gradec, Slovenia)
15.30 – 16.00 Coffee break
16.00 – 17.50 Peritoneal dialysis
Chairs: Bojan Knap (Ljubljana, Slovenia), Jernej Pajek (Ljubljana, Slovenia)

16.00 – 16.25 Peritoneal dialysis related infections. Sanjin Rački (Rijeka, Croatia)




16.30 – 16.45 Peritoneal dialysis in patients with chronic congestive heart failure.
Robert Ekart (Maribor, Slovenia)
16.50 – 17.05 Spironolactone for peritoneal dialysis patients – effects on heart
and peritoneal membrane. Jernej Pajek (Ljubljana, Slovenia)
17.10 – 17.25 Nutritional status and physical activity in peritoneal dialysis
patients. Bojan Knap (Ljubljana, Slovenia)
17.30 – 17.50 Discussion
18.00 General assembly of the Slovenian Society of Nephrology
20.30 Gala dinner
Saturday, November 26, 2016
8.00 – 9.50 Clinical nephrology and chronic kidney disease 1
Chairs: Radoslav Kveder (Ljubljana, Slovenia), Nika Kojc (Ljubljana, Slovenia)





8.00 – 8.25 Should we really STOP treating patients with IgA nephropathy with
steroids? Francesco Locatelli (Lecco, Italy)
8.30 – 8.45 Pathohistological prognostic factors of outcome in IgA nephropathy.
Nika Kojc (Ljubljana, Slovenia)
8.50 – 9.05 Membranous nephropathy. Andreja Aleš Rigler (Ljubljana, Slovenia)
9.10 – 9.25 Clinical relevance of kidney biopsy – where are we and where are we
going. Jelka Lindič (Ljubljana, Slovenia)
9.30 – 9.50 Discussion
9.50 – 10.20 Coffee break
10.20 – 13.00 Clinical nephrology and chronic kidney disease 2
Chairs: Radovan Hojs (Maribor, Slovenia), Dimitrij Klančič (Nova Gorica, Slovenia)






10.20 – 10.45 Water, salt and diuretics. Danilo Fliser (Homburg, Germany)
10.50 – 11.05 Treatment of cardiorenal syndrome with hemodialysis. Boštjan
Leskovar (Trbovlje, Slovenia)
11.10 – 11.25 The heart and the kidney. Sebastjan Bevc (Maribor, Slovenia)
11.30 – 11.45 Obesity. Radovan Hojs (Maribor, Slovenia)
11.50 – 12.05 Metabolic evaluation of patients with nephrolithiasis. Andrej
Škoberne (Ljubljana, Slovenia)
12.10 – 12.35 Is early nephrology care so important in stage 3b-4 CKD patients?
Goce Spasovski (Skopje, Macedonia)

12.40 – 13.00 Discussion
13.00 – 14.00 Lunch
14.00 – 15.00 Industry Sponsored Symposium – Alexion – Modern approaches to the
diagnosis and treatment of thrombotic microangiopathy (TMA)
Chair: Andreja Marn Pernat (Ljubljana, Slovenia)



14.00 – 14.20 TMA: view of the hematologist. Samo Zver (Ljubljana, Slovenia)
14.20 – 14.40 TMA: view of the nephrologist. Andreja Marn Pernat (Ljubljana,
Slovenia)
14.40 – 15.00 TMA and kidney transplantation. Miha Arnol (Ljubljana, Slovenia)
15.00 – 15.30 All in due time. Alenka Brecelj (Ljubljana, Slovenia)
15.30 – 17.00 Poster session
Chairs: Radoslav Kveder (Ljubljana, Slovenia), Andreja Aleš Rigler (Ljubljana,
Slovenia), Martina Lukač (Murska Sobota, Slovenia), Boštjan Kersnič (Novo
mesto, Slovenia)
17.00 – 19.00 Pediatric nephrology
Chairs: Rajko Kenda (Ljubljana, Slovenia), Tanja Kersnik Levart (Ljubljana, Slovenia)





17.00 – 17.15 Novelties in the clinical care of children with tuberous sclerosis.
Anamarija Meglič (Ljubljana, Slovenia)
17.20 – 17.35 Primary podocytopathies in children. Gregor Novljan (Ljubljana,
Slovenia)
17.40 – 18.10 Particularities of kidney transplantation in children with congenital
anomalies of the urinary tract:
– nephrological aspect. Nina Battelino (Ljubljana, Slovenia)
– urological aspect. Robert Kordič (Ljubljana, Slovenia)
18.15 – 18.45 Recommendations on the clinical care of children with end stage
renal failure and mental disability:
– legal aspects, ethical dilemmas and recommendations. Matjaž Kopač
(Ljubljana, Slovenia)
– clinical aspects. Rina Rus (Ljubljana, Slovenia)
18.45 – 19.00 Discussion
20.00 Social event
Sunday, November 27, 2016
8.00 – 10.10 Kidney transplantation 1
Chairs: Miha Arnol (Ljubljana, Slovenia), Gregor Mlinšek (Ljubljana, Slovenia)






8.00 – 8.25 Recipient desensitization - Can we prevent rejection? Georg Böhmig
(Vienna, Austria)
8.30 – 8.45 Antibodies directed to donor HLA tissue antigens. Blanka Vidan Jeras
(Ljubljana, Slovenia)
8.50 – 9.05 Noninvasive clinical biomarkers for antibody-mediated kidney
allograft rejection. Miha Arnol (Ljubljana, Slovenia)
9.10 – 9.25 Diagnostic significance of kidney biopsy in humoral rejection. Dušan
Ferluga (Ljubljana, Slovenia)
9.30 – 9.45 Treatment of humoral rejection. Damjan Kovač (Ljubljana, Slovenia)
9.50 – 10.10 Discussion
10.10 – 10.40 Coffee break
10.40 – 13.20 Kidney transplantation 2
Chairs: Andrej Bren (Ljubljana, Slovenia), Damjan Kovač (Ljubljana, Slovenia)







10.40 – 11.05 Living kidney donation. A safe procedure? Hallvard Holdaas (Oslo,
Norway)
11.10 – 11.25 Laparoscopic nephrectomy in living kidney donors. Simon Hawlina
(Ljubljana, Slovenia)
11.30 – 11.45 How to increase the number of transplanted kidneys in Slovenia?
Danica Avsec (Ljubljana, Slovenia)
11.50 – 12.05 Health-related quality of life after kidney transplantation. Andrej
Bren (Ljubljana, Slovenia)
12.10 – 12.35 Genetic contribution in cardiovascular disease after renal
transplantation. Sanja Simić Ogrizović (Belgrade, Serbia)
12.40 – 12.55 The role of CYP3A and ABCB1 single nucleotide polymorphisms on
cyclosporine and tacrolimus daily dose in kidney transplant recipients. Gregor
Mlinšek (Ljubljana, Slovenia)
13.00 – 13.20 Discussion
13.20 – 13.30 Congress closing
13.30 – 14.30 Lunch